These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study. Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488 [TBL] [Abstract][Full Text] [Related]
3. Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study. Larsen TB; Rasmussen LH; Gorst-Rasmussen A; Skjøth F; Lane DA; Lip GY Am J Med; 2014 Dec; 127(12):1172-8.e5. PubMed ID: 25193361 [TBL] [Abstract][Full Text] [Related]
4. Secondary stroke prevention with apixaban in nonvalvular atrial fibrillation: A subgroup analysis of the STANDARD study. Yasaka M; Umeyama M; Kataoka H; Inoue H J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105034. PubMed ID: 32807446 [TBL] [Abstract][Full Text] [Related]
5. Stroke: more protection for patients with atrial fibrillation. Albers GW Lancet Neurol; 2010 Jan; 9(1):2-4. PubMed ID: 20083021 [No Abstract] [Full Text] [Related]
6. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks. Koudstaal PJ Cochrane Database Syst Rev; 2000; (2):CD000185. PubMed ID: 10796313 [TBL] [Abstract][Full Text] [Related]
7. [Current management of antithrombotic treatment in patients with non valvular atrial fibrillation and prior history of stroke or transient ischemic attack]. Masjuán J; Álvarez-Sabín J; Blanco M; de Felipe A; Gil-Núñez A; Gállego-Culleré J; Vivancos J Rev Neurol; 2014 Jul; 59(1):25-36. PubMed ID: 24965928 [TBL] [Abstract][Full Text] [Related]
9. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks. Koudstaal PJ Cochrane Database Syst Rev; 2000; (2):CD000187. PubMed ID: 10796315 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks. Koudstaal PJ Cochrane Database Syst Rev; 2000; (2):CD000186. PubMed ID: 10796314 [TBL] [Abstract][Full Text] [Related]
13. WITHDRAWN: Antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks. Koudstaal PJ Cochrane Database Syst Rev; 1996 Apr; (1):CD000186. PubMed ID: 17636615 [TBL] [Abstract][Full Text] [Related]
14. Persistence of secondary prevention medication and related factors for acute ischemic stroke and transient ischemic attack in China. Jiang Y; Yang X; Li Z; Pan Y; Wang Y; Wang Y; Ji R; Wang C Neurol Res; 2017 Jun; 39(6):492-497. PubMed ID: 28420316 [TBL] [Abstract][Full Text] [Related]
15. Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III trial. Hart RG; Pearce LA; Koudstaal PJ Stroke; 2004 Apr; 35(4):948-51. PubMed ID: 14988571 [TBL] [Abstract][Full Text] [Related]
16. Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation. Koga M; Yoshimura S; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Todo K; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Yagita Y; Kario K; Shiozawa M; Sato S; Yamagami H; Arihiro S; Toyoda K; Stroke; 2016 Oct; 47(10):2582-8. PubMed ID: 27531346 [TBL] [Abstract][Full Text] [Related]
17. New Avenues for Optimal Treatment of Atrial Fibrillation and Stroke Prevention. De Marchis GM; Sposato LA; Kühne M; Dittrich TD; Bonati LH; Fischer U; Chaturvedi S Stroke; 2021 Apr; 52(4):1490-1499. PubMed ID: 33626906 [TBL] [Abstract][Full Text] [Related]
18. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Rothwell PM; Algra A; Amarenco P Lancet; 2011 May; 377(9778):1681-92. PubMed ID: 21571151 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Saxena R; Koudstaal P Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992 [TBL] [Abstract][Full Text] [Related]
20. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack. Saxena R; Koudstaal PJ Cochrane Database Syst Rev; 2004; (2):CD000185. PubMed ID: 15106146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]